Maliheh Davari: Exploring CRISPR Activation for Hemophilia at ISTH 2026
Maliheh Davari, Postdoctoral Fellow at Queen’s University, shared a post on LinkedIn:
“I am thrilled to announce that I had the opportunity to present my study, ‘Targeted CRISPRa-Mediated Enhancement of Inverted F8 Exon 1–22 Fragment Expression in Hemophilic Canine Endothelial Cells’, at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris.
It was a great privilege to share our work with researchers and clinicians from around the world and to engage in valuable scientific discussions.
I would like to express my sincere gratitude to my supervisor, Dr. David Lillicrap, for his invaluable mentorship, continuous guidance, and unwavering support throughout this project.
Presenting at ISTH has been an enriching experience, and I look forward to continuing this research and contributing to advances in the field of thrombosis and hemostasis.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?